European Healthtech startup funding raised during H2 2022.
In H2 2022, 308 European Healthtech companies raised a combined €4.1B across 327 funding rounds, down 28.4% versus H2 2021. UK led by capital raised, and Bpifrance was the most active investor. Data as of 9 Jul 2026.
| €157M |
| Vectivbio | Other | Oct 2022 | €127M |
| Novaremed | Other | Jul 2022 | €127M |
| TauRx Pharmaceuticals | Other | Nov 2022 | €115M |
| Demant AS | Debt | Nov 2022 | €115M |
| Kerecis | Series D+ | Jul 2022 | €99M |
| Osler Diagnostics | Series C | Nov 2022 | €85M |
| Sparingvision | Series B | Sep 2022 | €75M |
| Resolve Biosciences | Series B | Oct 2022 | €72M |
| Pheon Therapeutics | Series A | Sep 2022 | €71M |
| F2G | Other | Aug 2022 | €69M |
| Replay | Seed | Jul 2022 | €54M |